Plesner Louis Lind, Dalsgaard Morten, Schou Morten, Køber Lars, Vestbo Jørgen, Kjøller Erik, Iversen Kasper
Department of Cardiology, Herlev Hospital, Copenhagen University Hospital, Denmark.
Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark.
Clin Cardiol. 2017 Nov;40(11):1145-1151. doi: 10.1002/clc.22802. Epub 2017 Sep 13.
This study investigated the impact on all-cause mortality of airflow limitation indicative of chronic obstructive pulmonary disease or restrictive spirometry pattern (RSP) in a stable systolic heart failure population.
Decreased lung function indicates poor survival in heart failure.
Inclusion criteria: NYHA class II-IV and left ventricular ejection fraction (LVEF) < 45%. Prognosis was assessed with multivariate Cox proportional hazards models. Two criteria of obstructive airflow limitation were applied: FEV /FVC < 0.7 (GOLD), and FEV /FVC < lower limit of normality (LLN). RSP was defined as FEV /FVC > 0.7 and FVC<80% or FEV /FVC > LLN and FVC <LLN.
There where 573 patients in the cohort (85% of eligible patients in study period). Median follow-up was 4.7 years and 176 patients died (31%). Age, NYHA class, smoking, body mass index and LVEF were independent prognostic factors (p<0.01). Obstructive airflow limitation increased mortality using both criteria (HR 2.07 [95% CI 1.45-2.95] p<0.01 and HR 2.00 [1.40-2.84] p<0.01) and was an independent marker when using LLN criteria (HR 1.74 [1.17-2.59] p=0.006). RSP was independently associated with mortality when defined as FVC < LLN (HR 1.54 [1.01-2.35] p=0.04) but not as FVC < 80%. Multivariate hazard ratios for a 10% decrease in predicted value of FEV1 or FVC were 1.42 (p<0.001) and 1.33 (p<0.001) in patients exhibiting airflow obstruction, and 1.36 (p=0.031) and 1.38 (p=0.041) in RSP.
Presence of obstructive airflow limitation indicative of COPD or RSP were associated with increased all-cause mortality, however only independently when using the LLN definition.
本研究调查了稳定型收缩性心力衰竭患者中,提示慢性阻塞性肺疾病的气流受限或限制性肺量计模式(RSP)对全因死亡率的影响。
肺功能下降表明心力衰竭患者生存率低。
纳入标准:纽约心脏协会(NYHA)心功能II-IV级且左心室射血分数(LVEF)<45%。采用多变量Cox比例风险模型评估预后。应用两种阻塞性气流受限标准:FEV₁/FVC<0.7(全球慢性阻塞性肺疾病倡议组织(GOLD)标准),以及FEV₁/FVC<正常下限(LLN)。RSP定义为FEV₁/FVC>0.7且FVC<80%,或FEV₁/FVC>LLN且FVC<LLN。
队列中有573例患者(占研究期间符合条件患者的85%)。中位随访时间为4.7年,176例患者死亡(31%)。年龄、NYHA心功能分级、吸烟、体重指数和LVEF是独立的预后因素(p<0.01)。两种标准下阻塞性气流受限均增加死亡率(风险比(HR)2.07[95%置信区间(CI)1.45-2.95],p<0.01;HR 2.00[1.40-2.84],p<0.01),且采用LLN标准时是独立标志物(HR 1.74[1.17-2.59],p=0.006)。当定义为FVC<LLN时,RSP与死亡率独立相关(HR 1.54[1.01-2.35],p=0.04),而定义为FVC<80%时则不然。在出现气流阻塞的患者中,FEV₁或FVC预测值每降低10%的多变量风险比分别为1.42(p<0.001)和1.33(p<0.001),在RSP患者中分别为1.36(p=0.031)和1.38(p=0.041)。
提示慢性阻塞性肺疾病的阻塞性气流受限或RSP的存在与全因死亡率增加相关,但仅在使用LLN定义时具有独立性。